drugset / Trial / NCT01277211

A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

NCT01277211

Phase 3 Completed 983 enrolled Organon and Co
RandomizedParallel-groupOpen-labelPrevention

Summary

This is a study to assess the effectiveness of NuvaRing® (SCH 900702) for the prevention of pregnancy in fertile Chinese women. The acceptability and safety of NuvaRing® will also be assessed and compared with that of Yasmin.

Timeline

Start
2011-09-19
Primary completion
2013-09-18
Completion
2013-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject EE Unknown 15 ug Other
Comparator EE Unknown 30 ug Oral
Subject ENG Unknown 120 ug Other
Comparator drospirenone Unknown 3 mg Oral

Indications

No indication recorded.